Severe overdosage with the antiepileptic drug oxcarbazepine

British Journal of Clinical Pharmacology

Volumn 58, Issue 3, 2004, Pages 329-331

  Van Opstal, J M ^a,b   Janknegt, R ^b   Cilissen, J ^b   L'Ortije, W H V M ^a   Nel, J E ^a   De Heer, F ^a  

^a Sittard Geleen Heerlen   (Netherlands)

^b NONE   (Netherlands)

Author keywords

Oxcarbazepine; Prodrug; Toxicity

Indexed keywords

10 MONOHYDROXY DERIVATE; ACTIVATED CARBON; ANTICONVULSIVE AGENT; DRUG METABOLITE; OXCARBAZEPINE; PRODRUG; SODIUM SULFATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DRUG HALF LIFE; DRUG METABOLISM; DRUG OVERDOSE; EPILEPSY; HUMAN; MALE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TABLET;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSY; HUMANS; MALE; OVERDOSE;

EID: 4444356909     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2004.02129.x     Document Type: Article

References (10)

1. Faigle JW, Menge GP. Pharmacokinetic and metabolic features of oxcarbazepine and their clinical significance: comparison with carbamazepine. Int Clin Psychopharmacol 1990; 5 (Suppl. 1): 73-82.
2. Glauser. Oxcarbazepine in the treatment of epilepsy. Pharmacotherapy, 2001; 21: 904-19.
3. Johannessen SI, Battino D, Berry DJ et al. Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit 2003; 25: 347-63.
4. Wamil AW, Schmutz M, Portet C, Feldmann KF, McLean MJ. Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures. Eur J Pharmacol 1994; 271: 301-8.
5. McLean MJ, Schmutz M, Wamil AW, Olpe HR, Portet C, Feldman K. Oxcarbazepine: mechanisms of action. Epilepsia 1994; 35 (Suppl. 3): 5-9.
6. Borusiak P, Korn-Meker E, Holert N, Boenigk HE. Hyponatremia induced by oxcarbazepine in children. Epilepsy Res 1998; 30: 241-6.
7. Jolliff HA, et al. Bradycardia, hypotension and tinnitus after accidental oxcarbazepine overdose. Clin Toxicol 2001; 39: 316-17.
8. Raja M. Oxcarbazepine, risperidone and atenolol overdose with benign outcome. Int J Neuropsychopharmacol 2003; 6: 309-10.
9. Comparison of the Bioavailability of Three 600 mg Oxcarbazepine Solid Dosage Forms After Single Administration and at Steady State in Healthy Volunteers. Horsham, UK: Novartis Pharmaceuticals, 1998.
10. Flesch G, Tudor D, Souppart C, D'Souza J, Hossain M. Oxcarbazepine final market image tablet formulation bioequivalence study after single administration and at steady state in healthy subjects. Int J Clin Pharmacol Ther 2002; 40: 524-32.